| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/04/2009 | EP2030968A2 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof |
| 03/04/2009 | EP2029617A2 N-oxides of kappa opioid receptor peptides |
| 03/04/2009 | EP2029608A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use |
| 03/04/2009 | EP2029603A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor |
| 03/04/2009 | EP2029602A2 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 03/04/2009 | EP2029600A1 Substituted pteridines substituted with a four-membered heterocycle |
| 03/04/2009 | EP2029598A1 2-thioxanthine derivatives acting as mpo-inhibitors |
| 03/04/2009 | EP2029581A1 P38 inhibitors and methods of use thereof |
| 03/04/2009 | EP2029234A1 Treatment of gastrointestinal disorders with cgrp-antagonists |
| 03/04/2009 | EP2029233A2 Treatment of gastrointestinal disorders with cgrp antagonists |
| 03/04/2009 | EP1833795B1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 03/04/2009 | EP1519957B1 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
| 03/04/2009 | EP1463758B1 Mammalian prolactin variants |
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1418813A4 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/04/2009 | EP1379135B1 Formulations comprising entrapped active ingredients and uses thereof |
| 03/04/2009 | EP1045861B1 Bispecific targeting moiety comprising an antibody to carcinoembryonic antigen (cea) and the ligand-binding region of the il13 receptor alpha subunit |
| 03/04/2009 | EP0988054B1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| 03/04/2009 | CN201200627Y Ventilated type medicinal plaster for rheumatism and rheumatoid |
| 03/04/2009 | CN101379054A Piperidine derivatives as CXCR3 receptor antagonists |
| 03/04/2009 | CN101379041A Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 03/04/2009 | CN101378760A Pharmaceutical compositions comprising methotrexate |
| 03/04/2009 | CN101378756A Piperidine derivatives as CXCR3 receptor antagonists |
| 03/04/2009 | CN101378746A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| 03/04/2009 | CN101376654A Water-soluble aminoacid ester derivative of silibinin |
| 03/04/2009 | CN101376653A Flavonol compound, and preparation and use thereof |
| 03/04/2009 | CN101376651A Andrographolide and water-soluble aminoacid ester derivative of dewatered andrographolide |
| 03/04/2009 | CN101376020A Application of fungal immunomodulatory protein for inhibiting delta 5-desaturated enzyme |
| 03/04/2009 | CN101376009A (Compound honeybee and bovine colostrums) antirheumatic |
| 03/04/2009 | CN101375985A Pollen antirheumatic |
| 03/04/2009 | CN101375976A Moxa roll containing cattail pollen charcoal powder |
| 03/04/2009 | CN101375970A External-use liniment for arthralgia induced by hyperplasia of lumbar disc and cervical vertebra disc |
| 03/04/2009 | CN101375954A Medicament composition, preparation method thereof and use |
| 03/04/2009 | CN101375909A Moxa roll containing carbon powder of erberry |
| 03/04/2009 | CN101375873A Moxa roll containing Crinis carbonisatus powder |
| 03/04/2009 | CN101375868A Technique for extracting pine and cypress vigor element from branches and leaves, roots and barks, and flower bulbs of pine and cypress |
| 03/04/2009 | CN101375849A Novel dosage form of sinomenine medicament or hydrochlorate thereof and preparation technique thereof |
| 03/04/2009 | CN101375834A Solid dispersion of Ailamode and preparation method thereof and medicament application |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/04/2009 | CN100464784C A dietotherapy granule |
| 03/04/2009 | CN100464780C A hot compress medicine for treating omitis and a preparation method thereof |
| 03/04/2009 | CN100464760C An application of cocklebur fruit total glucoside extracts in preparing anti-inflammation reaction products |
| 03/04/2009 | CN100464743C N-acetylcysteine compositions for the treatment and prevention of drug toxicity |
| 03/04/2009 | CN100464742C NF-kB activation inhibitors |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498358 Human ADAM-10 inhibitors |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 03/03/2009 | US7498301 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 03/03/2009 | US7498157 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2009 | US7498139 Using presence of procalcitonin or procalcitonin partial peptides to detect septicemia; determining proprotein concentrations in sample |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498031 Treating sensorineural hearing loss or a vestibular disorder by administering an a PM-1antibody or an MR16-1 antibody; Meniere's disease, drug-induced inner ear disorders, viral inner ear disorders, purulent inner ear disorders, temporal bone fracture or acoustic nerve tumor |
| 03/03/2009 | CA2543986C Norepinephrine reuptake inhibitors and methods of using the same |
| 03/03/2009 | CA2433714C Arthritis preventing or treating agent |
| 03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
| 03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 02/26/2009 | WO2009026241A1 Heterocyclic modulators of tgr5 |
| 02/26/2009 | WO2009026158A2 Inflammation-regulating compositions and methods |
| 02/26/2009 | WO2009026107A1 Protein kinase inhibitors |
| 02/26/2009 | WO2009025300A1 Peptide capable of binding to immunoglobulin |
| 02/26/2009 | WO2009023903A1 Compositions comprising phospholipids |
| 02/26/2009 | WO2008152421A3 Modification of cytokine levels with glucosylamine compounds |
| 02/26/2009 | WO2008094222A3 Porphyrin catalysts and methods of use thereof |
| 02/26/2009 | WO2008035066A3 Processes for the preparation of ciclesonide and its crystal form |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054486 Polymorphic form xvi of fexofenadine hydrochloride |
| 02/26/2009 | US20090054483 Substituted Quinolines as Inhibitors of Leukotriene Biosynthesis |
| 02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |
| 02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
| 02/26/2009 | US20090054472 Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof |
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054465 N-hydroxyacrylamide compounds |
| 02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
| 02/26/2009 | US20090054452 Thienopyridine Derivatives and the Use Thereof as Hsp90 Modulators |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054446 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 02/26/2009 | US20090054425 Protein kinase inhibitors |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054413 Novel 5,6-Dihydropyrazolo[3,4-E] [L,4]Diazepin-4 (IH) -One Derivatives for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090054378 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 02/26/2009 | US20090054360 Method and Composition for Treating Allergic Diseases |
| 02/26/2009 | US20090054357 Macrolide compounds endowed with antiinflammatory activity |
| 02/26/2009 | US20090054345 Template-Fixed Beta-Hairpin Peptidomimetics With Protease Inhibitory Activity |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054311 Novel Cyclosporin Analog Formulations |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/26/2009 | US20090053285 Medicament Carrier Composition and Method Of Forming A Film Therefrom |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |